Your browser doesn't support javascript.
loading
Mitochondrial DNA Replication Defects Disturb Cellular dNTP Pools and Remodel One-Carbon Metabolism.
Nikkanen, Joni; Forsström, Saara; Euro, Liliya; Paetau, Ilse; Kohnz, Rebecca A; Wang, Liya; Chilov, Dmitri; Viinamäki, Jenni; Roivainen, Anne; Marjamäki, Päivi; Liljenbäck, Heidi; Ahola, Sofia; Buzkova, Jana; Terzioglu, Mügen; Khan, Nahid A; Pirnes-Karhu, Sini; Paetau, Anders; Lönnqvist, Tuula; Sajantila, Antti; Isohanni, Pirjo; Tyynismaa, Henna; Nomura, Daniel K; Battersby, Brendan J; Velagapudi, Vidya; Carroll, Christopher J; Suomalainen, Anu.
Afiliación
  • Nikkanen J; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Forsström S; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Euro L; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Paetau I; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Kohnz RA; Departments of Chemistry and Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.
  • Wang L; Department of Anatomy, Physiology, and Biochemistry, Swedish University of Agricultural Sciences, 75007 Uppsala, Sweden.
  • Chilov D; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Viinamäki J; Department of Forensic Medicine, University of Helsinki, 00300 Helsinki, Finland.
  • Roivainen A; Turku PET Centre, University of Turku, 20520 Turku, Finland; Turku Center for Disease Modeling, Institute of Biomedicine, University of Turku, 20520 Turku, Finland.
  • Marjamäki P; Turku PET Centre, University of Turku, 20520 Turku, Finland.
  • Liljenbäck H; Turku PET Centre, University of Turku, 20520 Turku, Finland; Turku Center for Disease Modeling, Institute of Biomedicine, University of Turku, 20520 Turku, Finland.
  • Ahola S; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Buzkova J; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Terzioglu M; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Khan NA; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Pirnes-Karhu S; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Paetau A; HUSLAB and Department of Pathology, University of Helsinki, Helsinki University Hospital, 00290 Helsinki, Finland.
  • Lönnqvist T; Department of Child Neurology, Children's Hospital, University of Helsinki, Helsinki University Hospital, 00290 Helsinki, Finland.
  • Sajantila A; Department of Forensic Medicine, University of Helsinki, 00300 Helsinki, Finland.
  • Isohanni P; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland; Department of Child Neurology, Children's Hospital, University of Helsinki, Helsinki University Hospital, 00290 Helsinki, Finland.
  • Tyynismaa H; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland; Department of Medical and Clinical Genetics, University of Helsinki, 00290 Helsinki, Finland.
  • Nomura DK; Departments of Chemistry and Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.
  • Battersby BJ; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland.
  • Velagapudi V; Metabolomics Unit, Institute for Molecular Medicine Finland, University of Helsinki, 00290 Helsinki, Finland.
  • Carroll CJ; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland. Electronic address: christopher.carroll@helsinki.fi.
  • Suomalainen A; Research Programs Unit, Molecular Neurology, University of Helsinki, 00290 Helsinki, Finland; Department of Neurology, University of Helsinki, Helsinki University Hospital, 00290 Helsinki, Finland; Neuroscience Center, University of Helsinki, 00790 Helsinki, Finland. Electronic address: anu.wartiova
Cell Metab ; 23(4): 635-48, 2016 Apr 12.
Article en En | MEDLINE | ID: mdl-26924217
ABSTRACT
Mitochondrial dysfunction affects cellular energy metabolism, but less is known about the consequences for cytoplasmic biosynthetic reactions. We report that mtDNA replication disorders caused by TWINKLE mutations-mitochondrial myopathy (MM) and infantile onset spinocerebellar ataxia (IOSCA)-remodel cellular dNTP pools in mice. MM muscle shows tissue-specific induction of the mitochondrial folate cycle, purine metabolism, and imbalanced and increased dNTP pools, consistent with progressive mtDNA mutagenesis. IOSCA-TWINKLE is predicted to hydrolyze dNTPs, consistent with low dNTP pools and mtDNA depletion in the disease. MM muscle also modifies the cytoplasmic one-carbon cycle, transsulfuration, and methylation, as well as increases glucose uptake and its utilization for de novo serine and glutathione biosynthesis. Our evidence indicates that the mitochondrial replication machinery communicates with cytoplasmic dNTP pools and that upregulation of glutathione synthesis through glucose-driven de novo serine biosynthesis contributes to the metabolic stress response. These results are important for disorders with primary or secondary mtDNA instability and offer targets for metabolic therapy.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ADN Mitocondrial / Degeneraciones Espinocerebelosas / Miopatías Mitocondriales / Mitocondrias / Nucleótidos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Metab Asunto de la revista: METABOLISMO Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ADN Mitocondrial / Degeneraciones Espinocerebelosas / Miopatías Mitocondriales / Mitocondrias / Nucleótidos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Metab Asunto de la revista: METABOLISMO Año: 2016 Tipo del documento: Article